Functional Constipation in Children

Definition and epidemiology

Functional constipation is infrequent or painful defecation without an identifiable organic cause. It accounts for roughly 95% of childhood constipation and affects an estimated 0.7–29% of children worldwide, with a typical onset at three transition points: weaning, toilet training, and school entry. A self-perpetuating cycle of painful stool → withholding → harder stool → more pain drives most cases, often complicated by faecal impaction and overflow soiling.

Clinical features

• Reduced stool frequency (often large-calibre stools that may block the toilet)
• Painful or hard bowel movements, sometimes with streaks of fresh blood from a fissure
• Retentive posturing — stiffening, tiptoeing, crossing legs, hiding — frequently mistaken for straining to pass stool
• Faecal incontinence/encopresis (overflow around an impacted rectum)
• Abdominal pain, palpable faecal mass, reduced appetite
• A palpable mass on abdominal exam and/or a loaded rectum

Diagnosis

Functional constipation is a clinical diagnosis based on the Rome IV criteria — no routine bloods or imaging are required when the history and exam are typical. For a child with a developmental age ≥4 years, at least two features for ≥1 month (with insufficient criteria for IBS): ≤2 defecations/week in the toilet, ≥1 episode of incontinence/week, retentive posturing, painful/hard stools, a large faecal mass in the rectum, and large-diameter stools. Infant/toddler criteria use a 1-month duration with ≤2 stools/week.

See the full criteria: Rome IV Functional Constipation

Red flags (suggest organic disease — investigate)

• Delayed passage of meconium >48 h, or onset in the first month of life (Hirschsprung)
• Ribbon stools, explosive stool on PR exam, tight empty rectum
• Failure to thrive, bilious vomiting, abdominal distension
• Abnormal lower-spine/gluteal exam, sacral dimple, absent anal wink (spinal cord)
• Leg weakness, abnormal reflexes, or developmental regression
• Severe abdominal distension; perianal fistula/fissure suggesting Crohn’s

Management overview

1. Education and demystification — explain the withholding cycle to parents; it is not wilful and rarely organic.
2. Disimpaction first if impacted: oral PEG (polyethylene glycol) with an escalating regimen over 3–7 days; enemas only if oral fails.
3. Maintenance with PEG as first-line osmotic laxative, titrated to one soft stool/day; continue for months, weaning slowly to avoid relapse.
4. Behavioural toileting — regular post-meal toilet sits using the gastrocolic reflex, foot support, a reward/diary system.
5. Diet/fluids — adequate fibre and fluids as adjuncts (not a substitute for laxatives in established constipation).
6. Follow-up to prevent the commonest failure mode: stopping laxatives too early.

India-aware note: lactulose remains widely used and affordable where PEG access is limited; counsel against unsupervised stimulant-laxative or “gripe-water” use and screen for hypothyroidism/coeliac only where clinically indicated.

References

• Rome IV Diagnostic Criteria (2016)
• ESPGHAN/NASPGHAN functional constipation guideline (2014)
• NICE CG99
• IAP constipation guidance

Decision support for qualified clinicians only — verify against current primary guidelines and your clinical judgement.